Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Active Antibody-mediated Rejection With Bortezomib in Kidney Transplantation

NCT02201576 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT02201576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02201576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Active Antibody-mediated Rejection With Bortezomib in Kidney Transplantation
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 2
Overall status
Completed
Start date
February 11, 2015
Completion date
July 16, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic antibody-mediated transplant rejection